Natural killer cells and human immunodeficiency virus

Domenico Mavilio, Anne Hosmalin, Daniel Scott-Algara

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

HIV-1 viraemia significantly impairs natural killer (NK) cell antiviral functions. Starting from acute infection, there is a pathologic redistribution of circulating NK cell subset that severely affects the ability of NK cells to eliminate HIV-1 infected cells. High frequencies of pathologic CD56neg/CD16pos NK cell subsets are associated with defective NK-DC interactions resulting in impaired activation and proliferation of NK cells, and deficient NK cell-mediated cytotoxicity and secretion of antiviral cytokines. Control of HIV-1 viraemia by antiretroviral therapy (ART) normalizes these parameters. TLR9 ligands may stimulate NK cells through pDC secretion of interferon (IFN)α. Cohorts of exposed, uninfected individuals and genetic studies show protective associations between some NK inhibitory receptors and their HLA class I molecule ligands. These data offer new molecular targets for HIV-1 control through restoration of NK cell functions. Natural killer (NK) cells are a subset of lymphoid cells that function as important mediators of innate immune defence against viruses and tumor cells. Understanding the biology of NK cells, particularly the identification of novel receptors and their ligands, has enhanced our knowledge on the potential role of NK cells in the immunopathogenesis of HIV infection. However, it is still unclear whether NK cells actually control HIV replication in vivo. Previous studies have attempted to evaluate the role of NK cells in the pathogenesis of several diseases or in the control of invading pathogens in nonhuman primates. The lack of specific markers that identify the entire simian NK cell population have significantly limited the understanding of the role of this population in disease states for which only nonhuman primates offer an appropriate animal model.

Original languageEnglish
Title of host publicationNatural Killer Cells
PublisherElsevier Ltd
Pages481-497
Number of pages17
ISBN (Print)9780123704542
DOIs
Publication statusPublished - 2010

Fingerprint

Viruses
Natural Killer Cells
HIV
Ligands
Antiviral Agents
Cells
KIR Receptors
Pathogens
Cytotoxicity
Set theory
HIV-1
Interferons
Restoration
Tumors
Animals
Chemical activation
Cytokines
Viremia
Molecules
Primates

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Mavilio, D., Hosmalin, A., & Scott-Algara, D. (2010). Natural killer cells and human immunodeficiency virus. In Natural Killer Cells (pp. 481-497). Elsevier Ltd. https://doi.org/10.1016/B978-0-12-370454-2.00036-3

Natural killer cells and human immunodeficiency virus. / Mavilio, Domenico; Hosmalin, Anne; Scott-Algara, Daniel.

Natural Killer Cells. Elsevier Ltd, 2010. p. 481-497.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mavilio, D, Hosmalin, A & Scott-Algara, D 2010, Natural killer cells and human immunodeficiency virus. in Natural Killer Cells. Elsevier Ltd, pp. 481-497. https://doi.org/10.1016/B978-0-12-370454-2.00036-3
Mavilio D, Hosmalin A, Scott-Algara D. Natural killer cells and human immunodeficiency virus. In Natural Killer Cells. Elsevier Ltd. 2010. p. 481-497 https://doi.org/10.1016/B978-0-12-370454-2.00036-3
Mavilio, Domenico ; Hosmalin, Anne ; Scott-Algara, Daniel. / Natural killer cells and human immunodeficiency virus. Natural Killer Cells. Elsevier Ltd, 2010. pp. 481-497
@inbook{44bf9e887bea44aba639e3a4bbb4b0dc,
title = "Natural killer cells and human immunodeficiency virus",
abstract = "HIV-1 viraemia significantly impairs natural killer (NK) cell antiviral functions. Starting from acute infection, there is a pathologic redistribution of circulating NK cell subset that severely affects the ability of NK cells to eliminate HIV-1 infected cells. High frequencies of pathologic CD56neg/CD16pos NK cell subsets are associated with defective NK-DC interactions resulting in impaired activation and proliferation of NK cells, and deficient NK cell-mediated cytotoxicity and secretion of antiviral cytokines. Control of HIV-1 viraemia by antiretroviral therapy (ART) normalizes these parameters. TLR9 ligands may stimulate NK cells through pDC secretion of interferon (IFN)α. Cohorts of exposed, uninfected individuals and genetic studies show protective associations between some NK inhibitory receptors and their HLA class I molecule ligands. These data offer new molecular targets for HIV-1 control through restoration of NK cell functions. Natural killer (NK) cells are a subset of lymphoid cells that function as important mediators of innate immune defence against viruses and tumor cells. Understanding the biology of NK cells, particularly the identification of novel receptors and their ligands, has enhanced our knowledge on the potential role of NK cells in the immunopathogenesis of HIV infection. However, it is still unclear whether NK cells actually control HIV replication in vivo. Previous studies have attempted to evaluate the role of NK cells in the pathogenesis of several diseases or in the control of invading pathogens in nonhuman primates. The lack of specific markers that identify the entire simian NK cell population have significantly limited the understanding of the role of this population in disease states for which only nonhuman primates offer an appropriate animal model.",
author = "Domenico Mavilio and Anne Hosmalin and Daniel Scott-Algara",
year = "2010",
doi = "10.1016/B978-0-12-370454-2.00036-3",
language = "English",
isbn = "9780123704542",
pages = "481--497",
booktitle = "Natural Killer Cells",
publisher = "Elsevier Ltd",

}

TY - CHAP

T1 - Natural killer cells and human immunodeficiency virus

AU - Mavilio, Domenico

AU - Hosmalin, Anne

AU - Scott-Algara, Daniel

PY - 2010

Y1 - 2010

N2 - HIV-1 viraemia significantly impairs natural killer (NK) cell antiviral functions. Starting from acute infection, there is a pathologic redistribution of circulating NK cell subset that severely affects the ability of NK cells to eliminate HIV-1 infected cells. High frequencies of pathologic CD56neg/CD16pos NK cell subsets are associated with defective NK-DC interactions resulting in impaired activation and proliferation of NK cells, and deficient NK cell-mediated cytotoxicity and secretion of antiviral cytokines. Control of HIV-1 viraemia by antiretroviral therapy (ART) normalizes these parameters. TLR9 ligands may stimulate NK cells through pDC secretion of interferon (IFN)α. Cohorts of exposed, uninfected individuals and genetic studies show protective associations between some NK inhibitory receptors and their HLA class I molecule ligands. These data offer new molecular targets for HIV-1 control through restoration of NK cell functions. Natural killer (NK) cells are a subset of lymphoid cells that function as important mediators of innate immune defence against viruses and tumor cells. Understanding the biology of NK cells, particularly the identification of novel receptors and their ligands, has enhanced our knowledge on the potential role of NK cells in the immunopathogenesis of HIV infection. However, it is still unclear whether NK cells actually control HIV replication in vivo. Previous studies have attempted to evaluate the role of NK cells in the pathogenesis of several diseases or in the control of invading pathogens in nonhuman primates. The lack of specific markers that identify the entire simian NK cell population have significantly limited the understanding of the role of this population in disease states for which only nonhuman primates offer an appropriate animal model.

AB - HIV-1 viraemia significantly impairs natural killer (NK) cell antiviral functions. Starting from acute infection, there is a pathologic redistribution of circulating NK cell subset that severely affects the ability of NK cells to eliminate HIV-1 infected cells. High frequencies of pathologic CD56neg/CD16pos NK cell subsets are associated with defective NK-DC interactions resulting in impaired activation and proliferation of NK cells, and deficient NK cell-mediated cytotoxicity and secretion of antiviral cytokines. Control of HIV-1 viraemia by antiretroviral therapy (ART) normalizes these parameters. TLR9 ligands may stimulate NK cells through pDC secretion of interferon (IFN)α. Cohorts of exposed, uninfected individuals and genetic studies show protective associations between some NK inhibitory receptors and their HLA class I molecule ligands. These data offer new molecular targets for HIV-1 control through restoration of NK cell functions. Natural killer (NK) cells are a subset of lymphoid cells that function as important mediators of innate immune defence against viruses and tumor cells. Understanding the biology of NK cells, particularly the identification of novel receptors and their ligands, has enhanced our knowledge on the potential role of NK cells in the immunopathogenesis of HIV infection. However, it is still unclear whether NK cells actually control HIV replication in vivo. Previous studies have attempted to evaluate the role of NK cells in the pathogenesis of several diseases or in the control of invading pathogens in nonhuman primates. The lack of specific markers that identify the entire simian NK cell population have significantly limited the understanding of the role of this population in disease states for which only nonhuman primates offer an appropriate animal model.

UR - http://www.scopus.com/inward/record.url?scp=84884737617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884737617&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-370454-2.00036-3

DO - 10.1016/B978-0-12-370454-2.00036-3

M3 - Chapter

AN - SCOPUS:84884737617

SN - 9780123704542

SP - 481

EP - 497

BT - Natural Killer Cells

PB - Elsevier Ltd

ER -